Efficacy and Safety Over 26 Weeks of an Oral Treatment Strategy Including Sitagliptin Compared With an Injectable Treatment Strategy With Liraglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: A Randomised Clinical Trial

Diabetologia - Germany

doi 10.1007/s00125-013-2905-1